Medicure Inc., a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, announced that it has granted stock options to certain officers of the Company to purchase a total of 90,000 common shares at a price of $1.10 per common share.
July 30, 2021
· 1 min read